Abbott debuts FreeStyle Libre 3 Plus in Canada, enhancing diabetes care with the world's smallest glucose sensor.

SAVE $40: Grab the Kobo Libra Colour for just $209.99 at Amazon as of July 8. This Prime Day deal saves you 16% off the ...

Two experts discuss why more research is needed before continuous glucose monitors can be used reliably for insulin ...

Abbott (NYSE: ABT) today announced that its latest generation of sensor-based glucose monitoring technology, the FreeStyle ...

Healthcare giants AbbVie and Abbott Laboratories are both Dividend Kings. They should maintain their dividend growth habits ...

The Shark CryoGlow LED Face Mask has a fan base among our group of testers, who loved virtually everything about the experience — from how comfortably the mask fit to how simple the remote ...

Freestyle Hard conjures an uncanny atmosphere where fiction and reality overlap, and sound becomes a medium of transformation and coded communication. Reyes was recently featured in ‘Flow States – La ...

Abbott's mixed reality technology helps distract blood donors and reduce their anxiety levels. This can help encourage young ...

The global continuous glucose monitoring device market is estimated to be valued at USD 12,690.7 million in 2025 and is projected to reach USD 54,553.1 million by 2035, registering a CAGR of 15.7% ...

The market increasingly favours closed-loop tech with extended sensor life, real-time glucose visibility and intelligent ...

Key collaborations enable Abbott to increase its global presence and accessibility to patients who haven't used CGMs before.

CGM devices like FreeStyle Libre offer real-time glucose readings, helping you stay within your target range and reduce the risk of long-term complications. With the right tools, you can manage your ...